Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) Net Income towards Common Stockholders (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Net Income towards Common Stockholders for 9 consecutive years, with $63.8 million as the latest value for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders rose 120.08% year-over-year to $63.8 million; the TTM value through Mar 2026 reached -$893.2 million, down 73.97%, while the annual FY2025 figure was -$311.3 million, 98.3% down from the prior year.
  • Net Income towards Common Stockholders hit $63.8 million in Q1 2026 for Select Medical Holdings, up from -$311.3 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $66.3 million in Q2 2022 and bottomed at -$376.4 million in Q4 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$95.7 million, with a median of $39.7 million recorded in 2024.
  • Year-over-year, Net Income towards Common Stockholders crashed 910.12% in 2025 and then soared 120.08% in 2026.
  • Select Medical Holdings' Net Income towards Common Stockholders stood at -$376.4 million in 2022, then skyrocketed by 39.46% to -$227.9 million in 2023, then dropped by 27.86% to -$291.4 million in 2024, then fell by 6.86% to -$311.3 million in 2025, then soared by 120.48% to $63.8 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $63.8 million, -$311.3 million, and -$321.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.